CN102018946A - Medicament for treating scapulohumeral periarthritis - Google Patents
Medicament for treating scapulohumeral periarthritis Download PDFInfo
- Publication number
- CN102018946A CN102018946A CN 201010550324 CN201010550324A CN102018946A CN 102018946 A CN102018946 A CN 102018946A CN 201010550324 CN201010550324 CN 201010550324 CN 201010550324 A CN201010550324 A CN 201010550324A CN 102018946 A CN102018946 A CN 102018946A
- Authority
- CN
- China
- Prior art keywords
- scapulohumeral periarthritis
- medicament
- medicine
- rhizoma
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a medicament for treating scapulohumeral periarthritis, which is prepared through the following steps of: washing all the raw material medicines containing coralbean bark, zedoary, red paeonia, angelica, notopterygium root, atractylodes macrocephala koidz, liquorice and ginger with clean water, airing, grinding into fine powder, and encapsulating to prepare a capsule. The medicament of the invention is used for relaxing tendons and activating collaterals, activating blood and removing blood stasis as well as resisting inflammation and easing pain and has good curative effect for treating the scapulohumeral periarthritis and low recurrence rate, and the effective rate of the medicament is 93.3 percent through clinical observation.
Description
Technical field
The present invention relates to a kind of medicine for the treatment of scapulohumeral periarthritis, particularly relating to a kind of is the medicine of the treatment scapulohumeral periarthritis of crude drug preparation with Chinese medicine.
Background technology
Scapulohumeral periarthritis is one of common painful diseases of middle-aged and elderly people, can show as during the serious symptom of scapulohumeral periarthritis that pain increases the weight of, shoulder joint abduction, outward turning function limitation, has a strong impact on patient's life.The symptom in late period of scapulohumeral periarthritis often has the part patient shoulder muscle atrophy etc. to occur.
Though at present the medicine of treatment scapulohumeral periarthritis is a lot, mostly curative effect is general, and the western medicine medication is simple, and side effect is very big, takes the infringement of human body cardio-cerebrovascular particularly evidently for a long time, and is easy to generate Drug resistance, and long-time therapeutic effect is also not obvious.In recent years, homemade Chinese patent medicine increased, but because its prescription is dull, unreasonable, had the defective of function singleness, therapeutic effect difference.
Summary of the invention
The purpose of this invention is to provide a kind of medicine for the treatment of scapulohumeral periarthritis, this medicine relaxing muscles and tendons and activating QI and blood in the collateral, blood circulation promoting and blood stasis dispelling, anti-inflammatory and antalgic, treatment scapulohumeral periarthritis good effect, relapse rate is low.
The medicine that the present invention treats scapulohumeral periarthritis is that crude drug prepares by following parts by weight of traditional Chinese medicines:
Cortex erythrinae 70～75 Rhizoma Wenyujin Concisum 12～17
Radix Paeoniae Rubra 12～17 Radix Angelicae Sinensis 15～20
Rhizoma Et Radix Notopterygii 12～17 Rhizoma Atractylodis Macrocephalaes 12～17
Radix Glycyrrhizae 1～5 Rhizoma Zingiberis Recens 1～5.
Said medicine can be made any dosage form on the pharmaceutics, as tablet, pill, powder, capsule etc., the preferred dosage form of the present invention is a capsule.
The concrete preparation method of above-mentioned each component being made medicine of the present invention is that above-mentioned each crude drug is cleaned with clear water, dries, and grinds to form fine powder, makes medicine capsule of the present invention in incapsulating.
Usage and consumption: warm water takes, and one day twice, once two.
In the prescription of the present invention, Cortex erythrinae can be gone into the Liver Channel blood system, and expelling wind and removing dampness, and the network of passing through are to reach disease institute; The circulation of qi promoting of Rhizoma Wenyujin Concisum removing blood stasis, inducing menstruation to relieve menalgia; The Radix Paeoniae Rubra clearing away heat and cooling blood, eliminating stasis to stop pain; Chinese angelica blood supplementing is invigorated blood circulation, menstruction regulating and pain relieving, loosening bowel to relieve constipation; The Rhizoma Et Radix Notopterygii inducing diaphoresis to dispel wind is wet; Rhizoma Atractylodis Macrocephalae invigorating the spleen and benefiting QI, dampness diuretic, hidroschesis; The Radix Glycyrrhizae invigorating the spleen and replenishing QI, heat-clearing and toxic substances removing, expelling phlegm for arresting cough, relieving spasm to stop pain, coordinating the actions of various ingredients in a prescription; The Rhizoma Zingiberis Recens relieving the exterior syndrome by diaphoresis, warming middle-JIAO to arrest vomiting, warming the lung to relieve cough.More than all medicines share, relaxing muscles and tendons and activating QI and blood in the collateral, blood circulation promoting and blood stasis dispelling, anti-inflammatory and antalgic, treatment scapulohumeral periarthritis good effect, relapse rate is low.
For further investigating the clinical efficacy and the safety of medicine of the present invention, select 120 routine scapulohumeral periarthritis patients that the curative effect of medicine of the present invention is carried out clinical observation.
120 routine cases are divided into two groups at random, every group 60 example.All case all is diagnosed as scapulohumeral periarthritis according to " the clinical research guideline of new Chinese medicine treatment scapulohumeral periarthritis ".
Therapeutic Method:
The oral promazine sheet difficult to understand of matched group, every day 1 time, each 2; Cinmetacine, every day 3 times, each 1.The treatment group adopts medicine of the present invention, and one day twice, once two, 30 days was a course of treatment.
Criterion of therapeutical effect:
According to " the clinical research guideline of new Chinese medicine treatment scapulohumeral periarthritis " regulation, efficacy determination with reference to change situations such as symptom, signs, is divided into healing, produce effects, effective, invalid level Four based on the X ray examination.Cure: shoulder pain disappears, and it is normal that the shoulder joint range of activity is recovered.Produce effects: shoulder pain is alleviated obviously, and the shoulder joint range of activity is improved obviously.Effectively: shoulder pain is alleviated substantially, and the shoulder joint range of activity is partly improved.Invalid: clinical symptoms does not have change.
Two groups of case treatment back curative effect comparative results see Table 1.
Table 1 liang group case treatment back curative effect relatively
Clinical experiment is the result prove, drug effect of the present invention obviously is better than matched group, do not see any untoward reaction.
The specific embodiment
Embodiment 1
Get Cortex erythrinae 7.2Kg, Rhizoma Wenyujin Concisum 1.5Kg, Radix Paeoniae Rubra 1.5Kg, Radix Angelicae Sinensis 1.8Kg, Rhizoma Et Radix Notopterygii 1.5Kg, Rhizoma Atractylodis Macrocephalae 1.5Kg, Radix Glycyrrhizae 0.3Kg, Rhizoma Zingiberis Recens 0.3Kg, above-mentioned each crude drug is cleaned with clear water, dry, grind to form fine powder, make capsule in incapsulating.
Embodiment 2
Get Cortex erythrinae 7.5Kg, Rhizoma Wenyujin Concisum 1.2Kg, Radix Paeoniae Rubra 1.6Kg, Radix Angelicae Sinensis 1.5Kg, Rhizoma Et Radix Notopterygii 1.6Kg, Rhizoma Atractylodis Macrocephalae 1.6Kg, Radix Glycyrrhizae 0.5Kg, Rhizoma Zingiberis Recens 0.2Kg, above-mentioned each crude drug is cleaned with clear water, dry, grind to form fine powder, make capsule in incapsulating.
Claims (2)
1. medicine for the treatment of scapulohumeral periarthritis is that crude drug prepares by following parts by weight of traditional Chinese medicines:
Cortex erythrinae 70～75 Rhizoma Wenyujin Concisum 12～17
Radix Paeoniae Rubra 12～17 returns 15～20
Rhizoma Et Radix Notopterygii 12～17 Rhizoma Atractylodis Macrocephalaes 12～17
Radix Glycyrrhizae 1～5 Rhizoma Zingiberis Recens 1～5.
2. the medicine of treatment scapulohumeral periarthritis according to claim 1 is characterized in that described medicine is made capsule.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201010550324 CN102018946A (en) | 2010-11-15 | 2010-11-15 | Medicament for treating scapulohumeral periarthritis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201010550324 CN102018946A (en) | 2010-11-15 | 2010-11-15 | Medicament for treating scapulohumeral periarthritis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102018946A true CN102018946A (en) | 2011-04-20 |
Family
ID=43860996
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 201010550324 Pending CN102018946A (en) | 2010-11-15 | 2010-11-15 | Medicament for treating scapulohumeral periarthritis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102018946A (en) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1429616A (en) * | 2003-02-09 | 2003-07-16 | 卫永生 | New preparation of compound Chinese medicine for treating osteoarthritis and its preparation method |
| CN1299757C (en) * | 2003-06-16 | 2007-02-14 | 江苏康缘药业股份有限公司 | Chinese medicinal composition for treating scapulohumeral periarthritis and preparing method thereof |
-
2010
- 2010-11-15 CN CN 201010550324 patent/CN102018946A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1429616A (en) * | 2003-02-09 | 2003-07-16 | 卫永生 | New preparation of compound Chinese medicine for treating osteoarthritis and its preparation method |
| CN1299757C (en) * | 2003-06-16 | 2007-02-14 | 江苏康缘药业股份有限公司 | Chinese medicinal composition for treating scapulohumeral periarthritis and preparing method thereof |
Non-Patent Citations (4)
| Title |
|---|
| 《中医药信息》 19911231 刘志刚 《肩周炎的中医药治疗进展》 17-21 1-2 , 第2期 2 * |
| 《中国中医急症》 20080430 张仕玉等 《虞抟痹证论治浅析》 525-526 1-2 第17卷, 第4期 2 * |
| 《中国中医药报》 20030929 不详 《肩关节周围炎》 1-2 , 2 * |
| 《类证治裁》 19970228 林珮琴 《舒筋汤》 432 1-2 , 1 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102846918A (en) | Drug for treating faucitis | |
| CN103736018A (en) | Medicine for treating gallstones and preparation method thereof | |
| CN103877517A (en) | Traditional Chinese medicine for treating pneumonia | |
| CN104138486A (en) | Traditional Chinese medicine for treating chronic epididymitis | |
| CN101912567B (en) | Chinese medicinal prescription for treating chronic myocarditis | |
| CN104173546A (en) | Traditional Chinese medicine liquid for treating rhinitis | |
| CN104000933A (en) | Traditional Chinese medicine oral liquid for treating osteoproliferation | |
| CN101822780A (en) | Medicament for treating oral ulcer and preparation method thereof | |
| CN103721082B (en) | A kind of Chinese medicine composition of cure scapulohumeral periarthritis | |
| CN101926903A (en) | Chinese medicine preparation for curing facial paralysis | |
| CN104337989A (en) | Traditional Chinese medicine composition containing centipeda minima and frankincense for treating gout | |
| CN101954061B (en) | Medicine for treating chronic laryngitis | |
| CN104173727A (en) | Medicine for treating toothache | |
| CN103736047A (en) | Chinese herbal medicine formula for dispelling cold and preparation method thereof | |
| CN102526384B (en) | Medicament for treating rheumatism and preparation method thereof | |
| CN101239140A (en) | Chinese medicine for treating psoriasis | |
| CN101596270A (en) | A kind of medicine that is used for the treatment of chronic pharyngitis and preparation method thereof | |
| CN101502597B (en) | Medicament for treating stomachache and preparation method thereof | |
| CN103127349B (en) | Medicine for treating traumatic injury | |
| CN102743524B (en) | Traditional Chinese medicine for treating rheumatism | |
| CN102018946A (en) | Medicament for treating scapulohumeral periarthritis | |
| CN101966329A (en) | Medicament for treating rash | |
| CN105250956A (en) | Chinese herb composition for treating colitis | |
| CN105194411A (en) | Formula of traditional Chinese medicine for treating scapulobumeral periarthritis | |
| CN106853193A (en) | It is a kind of to treat Chinese medicine of rheumatoid arthritis and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Open date: 20110420 |